ARCHIVES

ACS Journal Cancer Refers I-ELCAP Studies to Office of Human Research Protections

This article is from The Cancer Letter archive.

Vol. 38 No. 01 | January 6, 2012

Download PDF Visit The Full Archive

Related Articles

Breslow Says NCI, Centers, States Should Collaborate On Cancer Control

June 1, 1984

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT.

April 21, 2000

NCAB Recommends Withdrawal Of CRCC Comprehensive Status

February 13, 1981

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

NIH Inquiry Finds No Impropriety In Treatment of Teddy DeVita

April 9, 1976